Premium
Initial Experiences with Continuous Ambulatory Peritoneal Dialysis
Author(s) -
Fenton Stanley S. A.,
Cattran Daniel C.,
Allen AnnFrances,
Rutledge Paul,
Ampil Mercedes,
Dadson Joseph,
Locking Heather,
Smith Susan D.,
Wilson Douglas R.
Publication year - 1979
Publication title -
artificial organs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 76
eISSN - 1525-1594
pISSN - 0160-564X
DOI - 10.1111/j.1525-1594.1979.tb01048.x
Subject(s) - continuous ambulatory peritoneal dialysis , medicine , peritonitis , discontinuation , peritoneal dialysis , ambulatory , surgery , dialysis , creatinine
Continuous ambulatory peritoneal dialysis (CAPD) has been initiated on 51 patients: 27 females (mean age — 43.9 years) and 24 males (mean age — 46.4 years). This group has been observed for a total of 1420 patient weeks of treatment (27.3 patient years). Thirty‐six episodes of peritonitis have been noted among 19 patients. The overall incidence was one episode per 39.4 patient weeks. Recurrent episodes of peritonitis resulted in discontinuation of CAPD in five (9.8%) of the patients. Three (5.9%) of the patients were unable to continue with CAPD because of its inability to control extracellular fluid balance. In the patients who transferred from intermittent peritoneal dialysis to CAPD, there was a 4.5 mg/dl drop in serum creatinine and a 34 mg/dl drop in mean BUN values. There was a rise of approximately 2 gm in the hemoglobin levels of this group of patients. If the problem of peritonitis can be solved, CAPD will become the dialytic treatment of choice for the majority of patients with end‐stage renal disease.